
Chai Discovery Hits Three Billion Dollar Valuation
A massive new funding round for an AI drug startup shows that Big Pharma is outsourcing its most critical early-stage molecular design.
Discover the newest research about AI innovations in 🤖 Machine Learning.

A massive new funding round for an AI drug startup shows that Big Pharma is outsourcing its most critical early-stage molecular design.

A new double-blind trial reveals that specialized medical AI still cannot match human doctors when prescribing antibiotics for complex hospital infections.

A new machine learning model uses simple blood and nutrition markers to predict which uterine cancer patients can safely skip aggressive surgery to preserve their fertility.

A massive cash injection for Canada’s clinical data platform exposes the deep friction between sovereign AI ambitions and fragmented provincial healthcare systems.

A new machine learning model predicts 30-day mortality for brain bleed patients using routine clinical data instead of expensive brain scans, challenging the assumption that advanced imaging is required for accurate prognosis.

A new AI model turns the standard complete blood count into an instant classifier for leukemia and severe infections, bypassing the slow manual slide review that delays critical care.

Health systems are outsourcing the clinical interview to algorithms, but the real test is whether doctors actually regain their time.

Specialty drug costs are eating health insurance budgets alive, forcing payers to automate the back office just to survive the margin squeeze.

A new model bypasses complex clinical charts to predict long-term death risk using nothing but raw billing codes.

Biotech companies are finding a second life for failed drug data, but recycling bad trials into predictive algorithms carries hidden risks.